Rapamycin
Human evidence and active trials are visible in this field
97 human-evidence records · 28 active trials · 194 visible funding records · 6,773 universities
Canadian Patent Publication
MORPHOLINO SUBSTITUTED UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS
Source-linked patent metadata for MORPHOLINO SUBSTITUTED UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS, including priority, record stage and longevity-topic connections.
Canadian publication snapshot
Application publication visible
This privacy-minimal view describes one official Canadian patent publication. It is not presented as a complete worldwide patent family.
- Representative publication
- CA2849189A1
- Earliest priority
- September 21, 2011
- Latest publication
- March 28, 2013
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Rapamycin88% metadata match
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →